{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:38:49Z","timestamp":1791826729677,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Heilongjiang Province Project of Applied Technology Research and Development","award":["2013GC13C104"],"award-info":[{"award-number":["2013GC13C104"]}]},{"name":"National Natural Science Foundation of Biological Science","award":["J1210069\/J0116"],"award-info":[{"award-number":["J1210069\/J0116"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.taap.2015.11.012","type":"journal-article","created":{"date-parts":[[2015,11,22]],"date-time":"2015-11-22T06:53:14Z","timestamp":1448175194000},"page":"43-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-\u03b2\/smad2\/3 and NF-\u03baB signaling pathways"],"prefix":"10.1016","volume":"290","author":[{"given":"Pengfei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2015.11.012_bb0005","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00535-012-0619-7","article-title":"Butein inhibits ethanol-induced activation of liver stellate cells through TGF-\u03b2, NF-\u03baB, p38, and JNK signaling pathways and inhibition of oxidative stress","volume":"48","author":"Szuster-Ciesielska","year":"2013","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.taap.2015.11.012_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2015.11.012_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(01)02655-2","article-title":"TGFbeta1 in liver fibrosis: time to change paradigms","volume":"502","author":"Bauer","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.taap.2015.11.012_bb0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.dld.2004.11.009","article-title":"AlphaSMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation","volume":"37","author":"Carpino","year":"2005","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.taap.2015.11.012_bb0025","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1440-1746.2008.05720.x","article-title":"Stephania tetrandra prevents and regresses liver fibrosis induced by carbon tetrachloride in rats","volume":"24","author":"Chor","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2015.11.012_bb0030","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1172\/JCI119815","article-title":"Hepatic fibrosis, glomerulosclerosis, and lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice","volume":"100","author":"Clouthier","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2015.11.012_bb0035","series-title":"Stellate cells and the development of liver cancer: therapeutic potential of targeting the stroma","author":"Coulouarn","year":"2014"},{"issue":"2","key":"10.1016\/j.taap.2015.11.012_bb0040","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2015.11.012_bb0045","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199306243282508","article-title":"The cellular basis of hepatic fibrosis","volume":"328","author":"Freidman","year":"1993","journal-title":"New Engl. J. Med"},{"key":"10.1016\/j.taap.2015.11.012_bb0050","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"issue":"Suppl.1","key":"10.1016\/j.taap.2015.11.012_bb0055","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis \u2013 from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2015.11.012_bb0060","doi-asserted-by":"crossref","first-page":"10551","DOI":"10.1016\/S0021-9258(17)34095-4","article-title":"Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo","volume":"269","author":"Friedman","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2015.11.012_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1755-1536-2-1","article-title":"Evaluation of intracellular signalling pathways in response to insulin-like growth factor I in apoptotic-resistant activated human hepatic stellate cells","volume":"2","author":"Gentilini","year":"2009","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.taap.2015.11.012_bb0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0167-4838(95)00202-2","article-title":"Molecular characteristics of dimethylnitrosamine-induced fibrotic liver collagen","volume":"1292","author":"George","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2015.11.012_bb0075","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","article-title":"Missing pieces in the NF-kappaB puzzle","volume":"109","author":"Ghosh","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.taap.2015.11.012_bb0080","doi-asserted-by":"crossref","first-page":"d793","DOI":"10.2741\/A812","article-title":"Roles of TGF-beta in hepatic fibrosis","volume":"7","author":"Gressner","year":"2002","journal-title":"Front. Biosci."},{"key":"10.1016\/j.taap.2015.11.012_bb0085","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-2007-991517","article-title":"Hepatic fibrogenesis","volume":"27","author":"Guo","year":"2007","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.taap.2015.11.012_bb0090","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/hep.510270514","article-title":"Inhibition of NF-kappa B in activated rat hepatic stellate cells by proteasome inhibitors and an I-kappa B super-repressor","volume":"27","author":"Hellerbrand","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2015.11.012_bb0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.taap.2009.07.030","volume":"240","author":"Choi","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2015.11.012_bb0100","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors","volume":"102","author":"Iredale","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2015.11.012_bb0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jb\/mvq121","article-title":"Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease","volume":"149","author":"Itoh","year":"2011","journal-title":"J. Biochem."},{"key":"10.1016\/j.taap.2015.11.012_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00428-002-0703-0","article-title":"Tissue remodeling following submassive hemorrhagic necrosis in rat livers induced by an intraperitoneal injection of dimethylnitrosamine","volume":"442","author":"Jin","year":"2003","journal-title":"Virchows Arch."},{"key":"10.1016\/j.taap.2015.11.012_bb0115","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.biomaterials.2010.10.023","article-title":"The use of low molecular weight heparinepluronic nanogels to impede liver fibrosis by inhibition the TGF-\u03b2\/Smad signaling pathway","volume":"32","author":"Lee","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.taap.2015.11.012_bb0120","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","article-title":"Phosphorylation meets ubiquitination: the control of NF-(kappa)B activity","volume":"18","author":"Karin","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.taap.2015.11.012_bb0125","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3892\/ijo.2014.2552","article-title":"TGF-\u03b2\/Smad signaling during hepatic fibro-carcinogenesis (review)","volume":"45","author":"Katsunoriyoshida","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.taap.2015.11.012_bb0130","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.taap.2015.11.012_bb0135","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/en.2006-1168","article-title":"The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21","volume":"148","author":"Kharitonenkov","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.taap.2015.11.012_bb0140","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00535-013-0783-4","article-title":"Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats","volume":"49","author":"Kaji","year":"2014","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.taap.2015.11.012_bb0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(03)00178-8","article-title":"Gliotoxin-mediated apoptosis of activated human hepatic stellate cells","volume":"39","author":"Kweon","year":"2003","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.taap.2015.11.012_bb0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/cen.12134","article-title":"Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status[J]","volume":"80","author":"Lee","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.taap.2015.11.012_bb0155","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/gut.2008.156307","article-title":"Toll-like receptors as targets in chronic liver diseases","volume":"58","author":"Mencin","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.taap.2015.11.012_bb0160","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2005.082701","article-title":"Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans","volume":"55","author":"Novo","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.taap.2015.11.012_bb0165","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1053\/j.gastro.2009.02.081","article-title":"Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis","volume":"136","author":"Oakley","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2015.11.012_bb0170","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2004.10.003","article-title":"Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis","volume":"128","author":"Oakley","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2015.11.012_bb0175","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mam.2007.09.002","article-title":"Myofibroblast-like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario","volume":"29","author":"Parola","year":"2008","journal-title":"Mol. Asp. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.taap.2015.11.012_bb0180","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1111\/j.1440-1746.2006.04659.x","article-title":"Molecular mechanisms of hepatic fibrogenesis","volume":"22","author":"Parsons","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2015.11.012_bb0185","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1172\/JCI37409","article-title":"Adenosine signaling contributes to ethanol-induced fatty liver in mice","volume":"119","author":"Peng","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2015.11.012_bb0190","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1600-0676.1998.tb00120.x","article-title":"Signal transduction in hepatic stellate cells","volume":"18","author":"Pinzani","year":"1998","journal-title":"Liver"},{"key":"10.1016\/j.taap.2015.11.012_bb0195","doi-asserted-by":"crossref","first-page":"10853","DOI":"10.1073\/pnas.0904187106","article-title":"FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response","volume":"106","author":"Potthoff","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2015.11.012_bb0200","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1073\/pnas.96.5.2345","article-title":"Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat","volume":"96","author":"Qi","year":"1999","journal-title":"Proc. Natl. Acad. U.S.A."},{"issue":"6","key":"10.1016\/j.taap.2015.11.012_bb0205","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1210\/jc.2012-1221","article-title":"Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis","volume":"97","author":"Reinehr","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.taap.2015.11.012_bb0210","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.taap.2015.11.012_bb0215","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver\u2014linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2015.11.012_bb0220","first-page":"2261","article-title":"Semiquantitative evaluation of hepatic fibrosis by measuring tissue hydroxyproline","volume":"45","author":"Toyoki","year":"1998","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.taap.2015.11.012_bb0225","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0030-1255351","article-title":"Chemokines in liver inflammation and fibrosis","volume":"30","author":"Wasmuth","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.taap.2015.11.012_bb0230","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1053\/gast.2001.27188","article-title":"Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats","volume":"121","author":"Wright","year":"2001","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1016\/j.taap.2015.11.012_bb0235","doi-asserted-by":"crossref","first-page":"15167","DOI":"10.1074\/jbc.M309798200","article-title":"Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone","volume":"279","author":"Xavier","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2015.11.012_bb0240","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/0-387-24180-9_5","article-title":"NF-kappaB, an evolutionarily conserved mediator of immune and inflammatory responses","volume":"560","author":"Xiao","year":"2005","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.taap.2015.11.012_bb0245","article-title":"Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes","author":"Xiao","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.taap.2015.11.012_bb0250","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/db08-0392","article-title":"Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice","volume":"58","author":"Xu","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.taap.2015.11.012_bb0255","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2010.02.027","article-title":"New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis","volume":"53","author":"Wang","year":"2010","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.taap.2015.11.012_bb0260","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/emboj\/18.5.1280","article-title":"Targeted disruption of SMAD 3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta","volume":"18","author":"Yang","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.taap.2015.11.012_bb0265","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.27060","article-title":"FGF21 protects against acetaminophen-induced hepatotoxicity by potentiating PGC-1alpha-mediated antioxidant capacity in mice","volume":"60","author":"Ye","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2015.11.012_bb0270","article-title":"Fibroblast growth factor (FGF21) protects mouse liver against D-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K\/Akt pathways","volume":"21","author":"Yu","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.taap.2015.11.012_bb0275","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbrc.2008.05.069","article-title":"Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice","volume":"372","author":"Yu","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X15301393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X15301393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T20:15:09Z","timestamp":1653596109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X15301393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":55,"alternative-id":["S0041008X15301393"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2015.11.012","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-\u03b2\/smad2\/3 and NF-\u03baB signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2015.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}